EHealth interventions and patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.

ABSTRACT:

Objective

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern, with increasing mortality rates driven by the obesity pandemic. Weight loss has been shown to improve MASLD outcomes, yet the effectiveness of eHealth interventions in MASLD management remains uncertain. We aimed to evaluate the effectiveness of eHealth interventions compared with standard care in improving health outcomes among patients with MASLD.

Design

A systematic review and meta-analysis were conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

Data sources

Relevant studies were retrieved from PubMed, Cochrane Central and Embase databases from inception to 26 April 2024.

Eligibility criteria

SUBMITTER: Zafar Y 

PROVIDER: S-EPMC11987102 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature